We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Plaque Excision System Designed for Small Vessels

By HospiMedica International staff writers
Posted on 21 Jun 2011
A system treats calcified and noncalcified lesion morphologies in small vessels, broadening minimally invasive treatment options for Peripheral Arterial Disease (PAD). More...


The TurboHawk Plaque Excision System boasts an innovative design that allows for greater cutting efficiency, providing physicians with more consistent performance and patients with a faster recovery period and shorter hospital visits. The core of the system is the Super Cutter Blade, comprised of four angled cutter blades with a unique design that addresses all plaque morphologies, including moderately to severe calcified lesions. The Smooth Cutter Blade, on the other hand, is designed for the treatment of mild-to-moderately calcified lesions with the added convenience of on-the-wire cleaning. Micro Efficient Compression (MEC) technology, based on tiny laser drilled holes in the nosecone, regulate the release of cleansing fluid to the lesion, allowing greater tissue collection.

Among the other advancements of the system are the turbo catheter jog, which consistently cuts across a wider vessel range, reducing the need for multiple catheters, and potentially reducing procedure costs. The versatile dual-jog configuration is effective in vessels of 3.5 mm - 7.0 mm in diameter, controlling maximum apposition force in smaller vessel diameters and improving cutter apposition force in increasing vessel diameters. A new four-layered, counter-wound drive shaft delivers more power to the cutting blade, with more efficient energy transfer to improve cutting performance and affording smoother passes with less effort to cut through the lesion. The TurboHawk Plaque Excision System is a product of Covidien (North Haven, CT, USA), and has been approved by the US Food and Drug Administration (FDA).

"The TurboHawk Plaque Excision System for small vessels will provide physicians and healthcare professionals with a minimally invasive solution that can improve patient outcomes in the treatment of PAD," said Joe Woody, president of vascular therapies at Covidien. "The new system further exemplifies Covidien's commitment to PAD and improving patients overall quality of life."

Related Links:

Covidien



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.